Also, ERBB2 activating mutations (S310F/Y, G292R, T862A, D769H, L869R, V842I, R678Q, G776V, S653C, R897W, and G660D) were detected in 2% (9/459) of patients with CC. Here, ERBB2 is linked to cholangiocarcinoma.